GlassScriptPhysician profile
Caroline C Brown
NPI 1326822925
$1,800.64
in general payments reported to CMS, 2019-2025
18 companies · $994 in 2025
The $994 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $806 · 2025: $994.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,800.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $337.39 | 2024-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $300.46 | 2024-2025 | Camzyos, Eliquis |
| Atricure, INC. | $285.97 | 2024-2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.56 | 2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $147.91 | 2024-2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $128.94 | 2024 | Arcalyst |
| Actelion Pharmaceuticals US, INC. | $77.62 | 2024-2025 | Uptravi, Opsumit |
| Inspire Medical Systems, INC. | $67.45 | 2024-2025 | Inspire |
| Pfizer INC. | $66.36 | 2024-2025 | |
| Novo Nordisk INC | $39.13 | 2024-2025 | Ozempic |
| Scpharmaceuticals INC. | $38.41 | 2025 | |
| Heartflow, INC. | $37.52 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $34.50 | 2024 | |
| Vital Connect, INC | $20.00 | 2024 | Vitalpatch Rtm |
| Alnylam Pharmaceuticals INC. | $19.20 | 2025 | Amvuttra |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $16.69 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $16.02 | 2024 | Farxiga |
| Altathera Pharmaceuticals LLC | $12.51 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.